Chicago Cornea Consultants Blog

Dr. Epstein one of the authors of paper in prestigious journal Cornea; Dr. Majmudar to perform demonstration treatments at the American Society of Cataract and Refractive Surgery (ASCRS) annual conference

Apps and features of popular devices such as smart phones and tablets can make a difference for patients with vision loss from a variety of ailments.

CCC is proud to participate in the Implantable Miniature Telescope (IMT) trial with the Department of Ophthalmology at Rush.  Read more about this opportunity for individuals with central-vision affecting end-stage macular degeneration and cataracts to potentially restore some visual abilities.

Drs. Majmudar and Epstein have both been named to the “PS250”- A group of surgeons identified as the 250 top innovators in premium intra-ocular lens (IOL) implant surgery.  This list is published once each year in the print edition of Premier Surgeon. The list is available for viewing at: http://www.premiersurgeon.com/index.php/ps250

Monofocal intraocular lens and multifocal intraocular lens are both effective vision correction options for patients undergoing cataract surgery, (which involves the surgical replacement of a cloudy lens), though many patients are unclear about what they are and what they can achieve. Let’s take a look at both kinds of IOL's right now.

If you suffer from keratoconus, there are many ways that it can be treated effectively. One such treatment is corneal collagen cross-linking (CXL). Let’s briefly look at this treatment and what it can accomplish.

Cataracts are a common eye problem that many people face, usually when they reach advanced age. Let’s take a moment to look at the various causes of cataracts and how they can be treated.

Thank you for visiting our blog. We are on Facebook, LinkedIn and Twitter. Click on this article to follow us online.